期刊文献+

30例应用CDV方案化疗的晚期神经母细胞瘤患儿的护理 被引量:4

Nursing of the thirty children with advanced neuroblastoma treated by cyclophosphamide, daunorubicin and vincristine (CDV)
原文传递
导出
摘要 目的 研究CDV方案治疗晚期神经母细胞瘤的毒副作用及护理特点.方法 选择2001年3月-2005年3月在我院进行CDV方案化疗的神经母细胞瘤患儿30例资料进行回顾性分析和总结.结果 通过积极科学的护理方法,认真细致的护理观察,能够有效减少胃肠道反应、肝功损害、出血性膀胱炎等副反应的发生,提高存活率.结论 CDV方案为治疗晚期神经母细胞瘤的有效方法,通过加强护理,可减少其毒副反应的发生,提高其安全性.
机构地区 [
出处 《中华现代护理杂志》 2007年第30期2863-2864,共2页 Chinese Journal of Modern Nursing
  • 相关文献

参考文献3

二级参考文献17

  • 1Matthay KK. Neuroblastoma: biology and therapy. Oncology(Huntingt),1997,11:1857-1866, 1869-1872,1875.
  • 2Kaneko M,Tsuchida Y, Mugishima H, et al. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYC-N amplification. J Pediatr Hematol Oncol, 2002,24:613-621.
  • 3Kletzel M, Katzenstein HM, Haut PR, et al. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study. J Clin Oncol, 2002, 20:2284-2292.
  • 4Castel V, Tovar JA, Costa E, el al. The role of surgery in stage IV neuroblastoma. J Pediatr Surg, 2002,37:1574-1578.
  • 5Stram DO, Matthay KK, O'Leary M, et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma:a report of two concurrent Children′s Cancer Group studies. J Clin Oncol,1996,14
  • 6Ponthan F, Borgstrom P, Hassan M, et al. The vitamin A analogues:13-cis retinoic acid, 9-cis retinoic acid and Ro 13-6307 inhibit neuroblasoma tumour growth in vivo. Med Pediatr Oncol, 2001,36 :127-131.
  • 7Izbicki T, Mazur J, Izbicka E. Epidemiology of neuroblastoma:analysis of a single institution. Anticancer Res,2003,23 (2C):1933-1938.
  • 8Shimizu M,Shimizu T,Adachi T,et al. Long-term survival in adult mediastinal neuroblastoma.Jpn J Thorac Cardiovasc Surg,2003,51 (7): 326-329.
  • 9Gaspar N,Hartmann O,Munzer C,et al. Neuroblastoma in adolescents. Cancer, 2003,98 (2): 349-355.
  • 10Ho R,Eggert A,Hishiki T,et al. Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res,2002,62(22): 6462-6466.

共引文献8

同被引文献18

  • 1冯晨,唐锁勤,黄东生,王建文,于芳,杨光.CEM为预处理方案的自体外周血造血干细胞移植治疗晚期神经母细胞瘤相关毒性及疗效观察[J].中国当代儿科杂志,2004,6(6):489-491. 被引量:3
  • 2唐锁勤.神经母细胞瘤的诊断及治疗[J].实用儿科临床杂志,2005,20(1):4-6. 被引量:21
  • 3唐锁勤,黄东生,王建文,冯晨,杨光.大剂量化疗造血干细胞移植治疗IV期神经母细胞瘤的长期疗效研究[J].中国当代儿科杂志,2006,8(2):93-96. 被引量:27
  • 4吕春梅,程淑萍,李淑艳.小儿神经母细胞瘤综合治疗的临床护理[J].实用肿瘤学杂志,2006,20(2):131-131. 被引量:1
  • 5Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology[J]. Lancet Oncol, 2003, 4(8):472-480.
  • 6Castel V, Tovar JA, Costa E, Cuadros J, Ruiz A, Rollan V, et al. The role of surgery in stage Ⅳ neuroblastoma [J]. J Pediatr Surg, 2002, 37(11):1574-1578.
  • 7Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma [J]. J Clin Oncol, 2004, 22(24) :4888-4892.
  • 8McWilliams NB, Hayes FA, Green AA, Smith El, Nitschke R, Ahshuler GA, et al. Cyclophosphamide/doxorubicin vs. cisplatin/ teuiposide in the treatment of children older than 12 months of age with disseminated neuroblastoma:a Pediatric Oncology Group Randomized Phase Ⅱ study [ J ]. Med Pediatr Oncol, 1995, 24 (3) : 176-180.
  • 9Kushner BH, Kramer K, Modak S, Qin LX, Yataghena K, Jhanwar SC, et al. Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma[J]. Pediatr Blood Cancer, 2009, 53 ( 1 ) : 17-22.
  • 10胡亚美 江载芳 诸福棠.实用儿科学[M]:7版[M].北京:人民卫生出版社,2002.1738-1739.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部